Su, Y., Chen, R., Liu, R., Chen, J., Zhu, S. (2026). Selective bladder preservation after neoadjuvant zanidatamab combined with tislelizumab and chemotherapy in patients with HER2-positive muscle-invasive bladder cancer (HARBOR): A multicenter study.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.7_suppl.tps887